Investigational Drug Information for Trodusquemine
✉ Email this page to a colleague
What is the development status for investigational drug Trodusquemine?
Trodusquemine is an investigational drug.
There have been 4 clinical trials for Trodusquemine.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2016.
The most common disease conditions in clinical trials are Diabetes Mellitus, Overweight, and Breast Neoplasms. The leading clinical trial sponsors are Genaera Corporation, DepYmed Inc., and Northwell Health.
Summary for Trodusquemine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 291 |
| WIPO Patent Applications | 204 |
| Japanese Patent Applications | 35 |
| Clinical Trial Progress | Phase 1 (2016-04-01) |
| Vendors | 25 |
Recent Clinical Trials for Trodusquemine
| Title | Sponsor | Phase |
|---|---|---|
| Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer | DepYmed Inc. | Phase 1 |
| Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer | Northwell Health | Phase 1 |
| An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers | Genaera Corporation | Phase 1 |
Clinical Trial Summary for Trodusquemine
Top disease conditions for Trodusquemine
Top clinical trial sponsors for Trodusquemine
US Patents for Trodusquemine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
